{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:14:04Z","timestamp":1783401244355,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.neulet.2026.138645","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:01:25Z","timestamp":1780012885000},"page":"138645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo"],"prefix":"10.1016","volume":"882","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9722-7425","authenticated-orcid":false,"given":"Nicolas","family":"Fritz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Johannesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla","family":"Osswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lannfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"S\u00f6derberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2026.138645_b0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the amyloid-beta peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2026.138645_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2024.103949","article-title":"Lecanemab demonstrates highly selective binding to A\u03b2 protofibrils isolated from Alzheimer\u2019s disease brains","volume":"130","author":"Johannesson","year":"2024","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neulet.2026.138645_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032014","article-title":"Large aggregates are the major soluble A\u03b2 species in AD brain fractionated with density gradient ultracentrifugation","volume":"7","author":"Sehlin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2026.138645_b0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00401-018-1846-7","article-title":"Diffusible, highly bioactive oligomers represent a critical minority of soluble A\u03b2 in Alzheimer\u2019s disease brain","volume":"136","author":"Hong","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neulet.2026.138645_b0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","article-title":"Anti-amyloid monoclonal antibodies for the treatment of Alzheimer\u2019s disease","volume":"38","author":"Cummings","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.neulet.2026.138645_b0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2026.138645_b0035","article-title":"Long\u2010term safety and efficacy of lecanemab in early Alzheimer\u2019s disease: results from the clarity AD open\u2010label extension study","volume":"21","author":"Van Dyck","year":"2025","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.neulet.2026.138645_b0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","article-title":"Lecanemab, aducanumab, and gantenerumab - binding profiles to different forms of amyloid-beta might explain efficacy and side effects in clinical trials for Alzheimer\u2019s disease","volume":"20","author":"S\u00f6derberg","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neulet.2026.138645_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70086","article-title":"Lecanemab preferentially binds to smaller aggregates present at early Alzheimer\u2019s disease","volume":"21","author":"Fertan","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neulet.2026.138645_b0050","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.neuron.2023.04.007","article-title":"Abundant A\u03b2 fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer\u2019s disease brains","volume":"111","author":"Stern","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2026.138645_b0055","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease","volume":"6","author":"Bard","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2026.138645_b0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neulet.2026.138645_b0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.2910260208","article-title":"Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)","volume":"26","author":"Tsuchiya","year":"1980","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.neulet.2026.138645_b0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cellimm.2018.07.008","article-title":"Similarities and differences in surface receptor expression by THP-1 monocytes and differentiated macrophages polarized using seven different conditioning regimens","volume":"332","author":"Forrester","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.neulet.2026.138645_b0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1742-2094-9-115","article-title":"A comparative review of cell culture systems for the study of microglial biology in Alzheimer\u2019s disease","volume":"9","author":"Stansley","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2026.138645_b0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2011-110977","article-title":"Gantenerumab: a novel human anti-A\u03b2 antibody demonstrates sustained cerebral amyloid-\u03b2 binding and elicits cell-mediated removal of human amyloid-\u03b2","volume":"28","author":"Bohrmann","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2026.138645_b0085","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1021\/pr500414q","article-title":"Fc Gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions","volume":"13","author":"Hayes","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.neulet.2026.138645_b0090","doi-asserted-by":"crossref","DOI":"10.1002\/alz.069220","article-title":"Neuropathological autopsy findings in an individual with Alzheimer\u2019s disease who received long-term treatment with lecanemab (BAN2401)","volume":"18","author":"Honig","year":"2022","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.neulet.2026.138645_b0095","article-title":"Clearance of beta-amyloid and tau aggregates is size dependent and altered by an inflammatory challenge","volume":"7","author":"Fertan","year":"2025","journal-title":"Brain Commun."},{"key":"10.1016\/j.neulet.2026.138645_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2024.103950","article-title":"Disease modifying effects of the amyloid-beta protofibril-selective antibody mAb158 in aged Tg2576 transgenic mice","volume":"130","author":"Rizoska","year":"2024","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neulet.2026.138645_b0105","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1038\/s41467-024-54779-w","article-title":"Homeostatic microglia initially seed and activated microglia later reshape amyloid plaques in Alzheimer\u2019s Disease","volume":"15","author":"Balig\u00e1cs","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neulet.2026.138645_b0110","doi-asserted-by":"crossref","first-page":"14156","DOI":"10.1523\/JNEUROSCI.4147-08.2008","article-title":"Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice","volume":"28","author":"Koenigsknecht-Talboo","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2026.138645_b0115","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41591-025-03574-1","article-title":"Microglial mechanisms drive amyloid-\u03b2 clearance in immunized patients with Alzheimer\u2019s disease","volume":"31","author":"van Olst","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2026.138645_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/alz.094860","article-title":"Lecanemab induces phenotypic change in glial and microglial cells in Alzheimer\u2019s disease models: vitro and vivo evidences","volume":"20","author":"Callizot","year":"2024","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.neulet.2026.138645_b0125","article-title":"The Alzheimer\u2019s therapeutic lecanemab attenuates A\u03b2 pathology by inducing an amyloid-clearing program in microglia","author":"Albertini","year":"2025","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2026.138645_b0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-065X.1998.tb01188.x","article-title":"IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation","volume":"163","author":"Jefferis","year":"1998","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.neulet.2026.138645_b0135","doi-asserted-by":"crossref","DOI":"10.1126\/science.ads3204","article-title":"Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA","author":"Pizzo","year":"2025","journal-title":"Science 389"},{"key":"10.1016\/j.neulet.2026.138645_b0140","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1456-24.2024","article-title":"Acute communication between microglia and nonparenchymal immune cells in the anti-A\u03b2 antibody-injected cortex","volume":"45","author":"Foley","year":"2025","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2026.138645_b0145","doi-asserted-by":"crossref","unstructured":"L.A. Johnson, K. Saito, A.V. Pallerla, J.L. Funnell, A.R. Ezzo, C.L. Song, D.A. Harrison, N.J. Norton, L.C. Moore, L.J. Van Eldik, D.W. Fardo, G.E. Cooper, J.M. Morganti, Clonal expansion of cytotoxic CD8+ T cells in lecanemab-associated ARIA, medRxiv (2025) 2025.09.17.25335728. doi: 10.1101\/2025.09.17.25335728.","DOI":"10.1038\/s41467-026-68921-3"},{"key":"10.1016\/j.neulet.2026.138645_b0150","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1021\/acs.nanolett.3c00187","article-title":"Structural dynamics of amyloid-\u03b2 protofibrils and actions of anti-amyloid-\u03b2 antibodies as observed by high-speed atomic force microscopy","volume":"23","author":"Watanabe-Nakayama","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.neulet.2026.138645_b0155","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1523\/JNEUROSCI.23-09-03745.2003","article-title":"Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation","volume":"23","author":"Wilcock","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2026.138645_b0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314450121","article-title":"Lecanemab blocks the effects of the A\u03b2\/fibrinogen complex on blood clots and synapse toxicity in organotypic culture","volume":"121","author":"Singh","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394026001448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394026001448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:16:55Z","timestamp":1783397815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394026001448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":32,"alternative-id":["S0304394026001448"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2026.138645","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2026.138645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"138645"}}